Tavneos label?

Do you want the full official prescribing information (FDA label) for Tavneos, or a quick summary of its key points? I can provide either.

Here’s a concise summary (US indication):
- What it is: Tavneos (avacopan), a C5a receptor antagonist.
- Indication: For adults with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) in combination with standard therapy including glucocorticoids, to induce remission.
- Dose: 30 mg taken by mouth twice daily, with or without food, in combination with glucocorticoids.
- Notes: It is used as part of induction therapy with standard treatment (not as a monotherapy). The label also covers safety, adverse effects, and drug interactions.

If you want the exact label sections (contraindications, warnings, adverse effects, interactions, pregnancy, dosing in special populations, etc.) or the latest official wording, I can provide those or point you to the official FDA label. Just tell me which format you prefer.